
Detail-oriented Formulation Scientist experienced in designing stable dosage forms, optimizing processes for commercial production, and executing rigorous stability studies. Developed and validated analytical methods in compliance with ICH/USP guidelines while preparing essential regulatory documentation for successful IND, NDA, and ANDA filings. Led investigations to troubleshoot formulation and analytical deviations, ensuring lab compliance with cGMP and cGLP standards.
Developed solid, liquid, and semi-solid dosage forms from lab scale to pilot batches.
Conducted pre-formulation, drug-excipient compatibility, and solubility studies.
Scaled up manufacturing processes and established Critical Process Parameters (CPPs).
Utilized QbD and DOE principles to optimize formulations and process controls.
Managed technology transfer to commercial production facilities